Cargando…

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies

Invasive fungal infections caused by drug-resistant organisms are an emerging threat to heavily immunosuppressed patients with hematological malignancies. Modern early antifungal treatment strategies, such as prophylaxis and empirical and preemptive therapy, result in long-term exposure to antifunga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamaletsou, Maria N., Walsh, Thomas J., Sipsas, Nikolaos V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843768/ https://www.ncbi.nlm.nih.gov/pubmed/29391334 http://dx.doi.org/10.4274/tjh.2018.0007

Ejemplares similares

Management of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations
por: Sipsas, Nikolaos V., et al.
Publicado: (2018)

Emerging Threats in Antifungal-Resistant Fungal Pathogens
por: Sanglard, Dominique
Publicado: (2016)

Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
por: Little, Jessica S., et al.
Publicado: (2021)

Performance, Correlation and Kinetic Profile of Circulating Serum Fungal Biomarkers of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies
por: Siopi, Maria, et al.
Publicado: (2021)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification
por: Chen, Lijin, et al.
Publicado: (2022)

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
por: Sfeir, Maroun M., et al.
Publicado: (2020)

Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis
por: Liu, Mingjuan, et al.
Publicado: (2014)

Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
por: Zeng, Huilan, et al.
Publicado: (2021)

Therapy of Mucormycosis
por: Sipsas, Nikolaos V., et al.
Publicado: (2018)

Antifungal Resistance and Predictors of Response in Patients with Hematologic Malignancy
por: Wey, Shiuan (Shannon), et al.
Publicado: (2017)

The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris
por: Rybak, Jeffrey M, et al.
Publicado: (2022)

Invasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive
por: Spallone, Amy, et al.
Publicado: (2020)

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
por: Bergamasco, Maria Daniela, et al.
Publicado: (2021)

Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?
por: Apostolidi, Eirini A., et al.
Publicado: (2023)

Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice
por: Rambaldi, Benedetta, et al.
Publicado: (2017)

Is Sjögren's syndrome a retroviral disease?
por: Sipsas, Nikolaos V, et al.
Publicado: (2011)

Antifungal Resistance and New Strategies to Control Fungal Infections
por: Vandeputte, Patrick, et al.
Publicado: (2012)

Fungal Cell Wall: Emerging Antifungals and Drug Resistance
por: Lima, Soraia L., et al.
Publicado: (2019)

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016)

Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies
por: Valković, Toni, et al.
Publicado: (2022)

2596. Invasive Fungal Disease in Patients with GATA2 Variant Hematologic Malignancy
por: Bold, Tyler D, et al.
Publicado: (2019)

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
por: Tscherner, Michael, et al.
Publicado: (2011)

Surgery for Pulmonary Fungal Infections Complicating Hematological Malignancies
por: Yamamichi, Takashi, et al.
Publicado: (2018)

A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria
por: Siopi, Maria, et al.
Publicado: (2021)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections
por: Xiao, Han, et al.
Publicado: (2020)

2100. Epidemiology and Risk Factors for Invasive Fungal Infections Among Patients with Hematological Malignancies In Colombia
por: Ortiz-Martínez, Yeimer, et al.
Publicado: (2022)

Fun(gi)omics: Advanced and Diverse Technologies to Explore Emerging Fungal Pathogens and Define Mechanisms of Antifungal Resistance
por: Ball, B., et al.
Publicado: (2020)

Emerging Metabolic Targets in the Therapy of Hematological Malignancies
por: Leni, Zaira, et al.
Publicado: (2013)

Evaluation of the Dynamiker(®) Fungus (1–3)-β-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies
por: Siopi, Maria, et al.
Publicado: (2022)

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination
por: Rojas, Rafael, et al.
Publicado: (2012)

The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies
por: Daraskevicius, Justinas, et al.
Publicado: (2022)

INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES – A FIVE-YEAR SINGLE CENTER EXPERIENCE
por: Buljan, Domagoj, et al.
Publicado: (2022)

Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-Series
por: Peri, Anna Maria, et al.
Publicado: (2019)

The Role of Antifungals in Pediatric Critical Care Invasive Fungal Infections
por: Kaushik, Ashlesha, et al.
Publicado: (2018)

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
por: Salih, Zena, et al.
Publicado: (2013)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents
por: Miller, Matthew A, et al.
Publicado: (2020)

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1rreauua640b1posc2kvuekenp